Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...
查看详情On September 5 2016,Bio-thera reached a strategic cooperation agreement with world class CRO, Quintiles. Under agreement...
Great news! On May 18, Bio-Thera's recombinant humanized anti-VEGF monoclonal antibody injection(BAT1706) was approved f...
On March 15, there was some big news for one of Bio-Thera's major pipeline products. The phase I clinical trial for BAT1...
